Private Market View

PostEra

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$28.4M
Last round
Early Stage VC (Series A)
Jan 2022
Valuation — not yet established

No valuation for PostEra is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($28.4M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·Watchlist + deal alerts for PostEra
Create free account
No card required

Funding history

2 rounds
DateRoundRaisedPost-money
Jan 2022Early Stage VC (Series A)$26.1M
Apr 2020Seed Round$2.4M

How PostEra's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For PostEra, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

How much has PostEra raised?
PostEra has raised $28.4M in total funding across 2 recorded rounds.
When did PostEra last raise?
PostEra last raised in Jan 2022 (Early Stage VC (Series A)), raising $26.1M.